Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Brand profile · Research Services
Omico runs a Research Services operation from Kensington, NSW. It is a nonprofit, and its site is omico.com.au. It holds one address on record, all in Australia. Headcount on record is 60. Its work is tagged cancer and genomics. The record links six similar brands, most of them in Research Services.
Omico is a nationwide precision oncology network of research and treatment centres that facilitates, supports, and promotes clinical trials in genomic cancer medicine.
Our vision is to improve outcomes for Australians with cancer by accelerating the use of precision oncology as a research-led model of care, growing the clinical trials industry and modernising the Australian healthcare system.
Central to this vision is the use of molecular screening for the prevention and treatment of cancer, personalised risk management, patient support and advocacy, and health system reform.
Our vision is reflected in our core values, which direct every aspect of our organisation: innovation, collaboration, and hope.
| Countries | 1 |
|---|---|
| Primary country | AU |
All codes: AU
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Hiring, headcount and registry-change signals, streamed to members.
Registry-filed capital and financial indicators, standardised by TheGrid.
4 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
Names are withheld until a consented source exists.
60 counted staff profiles at January 2026, above the self-reported 11–50 band.
One address on record, Australia only. Primary: Hilmer Building, Union Road, UNSW, Kensington, NSW 2052.
None linked to this brand.
Five tags on the brand's own list, among them cancer and genomics.
Six peer profiles on record: Medicines Australia and MedWise Consulting.